移动卒中单元调度对全部急性卒中或短暂性脑缺血发作患者的效果
基于柏林B_PROUD非随机研究和B-SPATIAL登记,比较额外调度移动卒中单元(MSU)与仅常规救护车对全部卒中或TIA患者3个月功能结局的影响。MSU组1125例,常规组1141例,经混杂调整后MSU调度与更优的3个月mRS评分相关(cOR=0.82,95%CI 0.71-0.94),共同主要结局及7天死亡率无统计学显著关联。
要点
- MSU调度与全部卒中或TIA患者3个月mRS评分更优相关(cOR=0.82,95%CI 0.71-0.94)。
- 共同主要结局3级残疾量表无统计学显著关联(cOR=0.86,95%CI 0.72-1.01)。
- 7天死亡率无统计学显著关联(OR=0.94,95%CI 0.59-1.48)。
核心结论
- 在全部卒中或TIA患者中,MSU调度改善3个月功能结局,无安全性受损证据。
研究设计与样本
- 非随机B_PROUD研究(2017年2月至2019年5月)及关联的B-SPATIAL卒中登记,MSU仅按可用性调度。
主要发现
- MSU组1125例(平均年龄74岁,女性46.5%),常规救护车组1141例(75岁,女性49.9%)。
- 混杂调整后MSU调度与更优的3个月mRS评分相关(cOR=0.82,95%CI 0.71-0.94)。
- 共同主要结局3级残疾量表无统计学显著关联(cOR=0.86,95%CI 0.72-1.01)。
- 7天死亡率无统计学显著关联(OR=0.94,95%CI 0.59-1.48)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the effect of additional mobile stroke unit (MSU) dispatch on functional outcomes among the full spectrum of stroke patients, regardless of subtype or potential contraindications to reperfusion therapies. METHODS: We used data from the nonrandomized Berlin-based B_PROUD study (02/2017 to 05/2019), in which MSUs were dispatched based solely on availability, and the linked B-SPATIAL stroke registry. All patients with final stroke or transient ischemic attack (TIA) diagnoses were eligible. The intervention under study was the additional dispatch of an MSU, an emergency physician-staffed ambulance equipped to provide prehospital imaging and thrombolytic treatment, compared to conventional ambulance alone. The primary outcome was the 3-month modified Rankin Scale (mRS) score, and the co-primary outcome was a 3-tiered disability scale. We identified confounders using directed acyclic graphs and obtained adjusted effect estimates using inverse probability of treatment weighting. RESULTS: MSUs were dispatched to 1,125 patients (mean age: 74 years, 46.5% female), while for 1,141 patients only conventional ambulances were dispatched (75 years, 49.9% female). After confounding adjustment, MSU dispatch was associated with more favorable 3-month mRS scores (common odds ratio [cOR] = 0.82; 95% confidence interval [CI]: 0.71-0.94). No statistically significant association was found with the co-primary outcome (cOR = 0.86; 9% CI: 0.72-1.01) or 7-day mortality (OR = 0.94; 95% CI: 0.59-1.48). INTERPRETATION: When considering the entire population of stroke/TIA patients, MSU dispatch improved 3-month functional outcomes without evidence of compromised safety. Our results are relevant for decision-makers since stroke subtype and treatment eligibility are unknown at time of dispatch. ANN NEUROL 2023;93:50-63.
引用
- Rohmann JL, Piccininni M, Ebinger M, et al. Effect of Mobile Stroke Unit Dispatch in all Patients with Acute Stroke or TIA. Ann Neurol. 2022. PMID: 36309933. doi:10.1002/ana.26541
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。